1. A Comparison of the α2/3/5 Selective Positive Allosteric Modulators L-838, 417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain. (28th November 2011) Authors: Nickolls, Sarah; Mace, Hannah; Fish, Rebecca; Edye, Michelle; Gurrell, Rachel; Ivarsson, Magnus; Pitcher, Tom; Tanimoto-Mori, Sachi; Richardson, Denise; Sweatman, Catherine; Nicholson, Janet; Ward, Cameron; Jinks, John; Bell, Christine; Young, Kimberly; Rees, Huw; Moss, Andrew; Kinloch, Ross; McM... Other Names: Atack John Academic Editor. Journal: Advances in pharmacological sciences Issue: Volume 2011(2011) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomised, placebo-controlled clinical trial with the α2/3/5 subunit selective GABAA positive allosteric modulator PF-06372865 in patients with chronic low back pain. Issue 9 (September 2018) Authors: Gurrell, Rachel; Dua, Pinky; Feng, Gang; Sudworth, Maria; Whitlock, Mark; Reynolds, David S.; Butt, Richard P. Journal: Pain Issue: Volume 159:Issue 9(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Acute kidney injury observed during phase 1 clinical trials of a novel xanthine oxidase/URAT1 dual inhibitor PF-06743649. Issue 8 (August 2016) Authors: Dua, Pinky; Gurrell, Rachel; Kirby, Simon; Sudworth, Maria; Loudon, Peter Journal: Clinical rheumatology Issue: Volume 35:Issue 8(2016) Page Start: 2045 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABAA partial agonist, in humans. (August 2019) Authors: van Amerongen, Guido; Siebenga, Pieter S.; Gurrell, Rachel; Dua, Pinky; Whitlock, Mark; Gorman, Donal; Okkerse, Pieter; Hay, Justin L.; Butt, Richard P.; Groeneveld, Geert Jan Journal: British journal of anaesthesia Issue: Volume 123:Number 2(2019) Page Start: e194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Considerations for determining the efficacy of new antiseizure medications in children age 1 month to younger than 2 years. Issue 10 (12th August 2022) Authors: French, Jacqueline A.; Cleary, Elena; Dlugos, Dennis; Farfel, Gail; Farrell, Kathleen; Gidal, Barry; Grzeskowiak, Caitlin L.; Gurrell, Rachel; Harden, Cynthia; Stalvey, Tracy J.; Tsai, Julia; Wirrell, Elaine C.; Blum, David; Fountain, Nathan Journal: Epilepsia Issue: Volume 63:Issue 10(2022) Page Start: 2664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pharmacology in translation: the preclinical and early clinical profile of the novel α2/3 functionally selective GABAA receptor positive allosteric modulator PF‐06372865. (18th January 2018) Authors: Nickolls, Sarah A; Gurrell, Rachel; van Amerongen, Guido; Kammonen, Juha; Cao, Lishuang; Brown, Adam R; Stead, Clara; Mead, Andy; Watson, Christine; Hsu, Cathleen; Owen, Robert M; Pike, Andy; Fish, Rebecca L; Chen, Laigao; Qiu, Ruolun; Morris, Evan D; Feng, Gang; Whitlock, Mark; Gorman, Donal; va... Journal: British journal of pharmacology Issue: Volume 175:Number 4(2018) Page Start: 708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pronounced antiepileptic activity of the subtype‐selective GABAA‐positive allosteric modulator PF‐06372865 in the GAERS absence epilepsy model. (12th August 2018) Authors: Duveau, Venceslas; Buhl, Derek L.; Evrard, Alexis; Ruggiero, Céline; Mandé‐Niedergang, Betty; Roucard, Corinne; Gurrell, Rachel Journal: CNS neuroscience & therapeutics Issue: Volume 25:Number 2(2019) Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pronounced antiseizure activity of the subtype‐selective GABAA positive allosteric modulator darigabat in a mouse model of drug‐resistant focal epilepsy. (14th August 2022) Authors: Gurrell, Rachel; Iredale, Philip; Evrard, Alexis; Duveau, Venceslas; Ruggiero, Céline; Roucard, Corinne Journal: CNS neuroscience & therapeutics Issue: Volume 28:Number 11(2022) Page Start: 1875 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety, Tolerability, and Pharmacokinetics of Multiple Repeated Oral Doses of the α2/3/5‐Subtype Selective GABAA‐Positive Allosteric Modulator PF‐06372865 in Healthy Volunteers. Issue 7 (19th January 2021) Authors: Gurrell, Rachel; Whitlock, Mark; Wei, Hua; Shen, Zhongzhou; Ogden, Adam Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 7(2021) Page Start: 756 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The use of a battery of pain models to detect analgesic properties of compounds: a two‐part four‐way crossover study. (9th January 2017) Authors: Okkerse, Pieter; van Amerongen, Guido; de Kam, Marieke L.; Stevens, Jasper; Butt, Richard P.; Gurrell, Rachel; Dahan, Albert; van Gerven, Joop M.; Hay, Justin L.; Groeneveld, Geert Jan Journal: British journal of clinical pharmacology Issue: Volume 83:Number 5(2017:May) Page Start: 976 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗